De-identified data that hospitals and health systems share with big tech can sometimes be used to identify patients. As these types of deals grow, full transparency with patients is key...
Effective communication with providers and patients can bridge the gap that exists between precision medicine’s benefits and wider patient access...
Focus on pharmacogenetics studies and data that demonstrate costs savings and improved outcomes...
Focusing on the right factors can accelerate a precision medicine program’s ROI...
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions...
Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in...
Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer....
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics...
Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information...
Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs...
